Danceanu-Zara Camelia-Mihaela, Petrovici Adriana, Labusca Luminita, Minuti Anca Emanuela, Stavila Cristina, Plamadeala Petru, Tiron Crina Elena, Aniţă Dragoş, Aniţă Adriana, Lupu Nicoleta
National Institute of Research and Development in Technical Physics, 700050 Iasi, Romania.
Transcend Center Regional Oncology Institute, 700483 Iasi, Romania.
Biomedicines. 2024 Oct 21;12(10):2406. doi: 10.3390/biomedicines12102406.
With the increasing burden of osteoarthritis worldwide, cost efficient and reliable models are needed to enable the development of innovative therapies or therapeutic interventions. Ex vivo models have been identified as valuable modalities in translational research, bridging the gap between in vitro and in vivo models. Osteocartilaginous explants from Osteoarthritis (OA) patients offer an exquisite opportunity for studying OA progression and testing novel therapies. We describe the protocol for establishing human osteocartilaginous explants with or without co-culture of homologous synovial tissue. Furthermore, a detailed protocol for the assessment of explanted tissue in terms of protein content using Western blot and immunohistochemistry is provided. Commentaries regarding the technique of choice, possible variations and expected results are inserted.
随着全球骨关节炎负担的日益加重,需要经济高效且可靠的模型来推动创新疗法或治疗干预措施的开发。体外模型已被视为转化研究中的重要手段,填补了体外和体内模型之间的空白。骨关节炎(OA)患者的骨软骨外植体为研究OA进展和测试新疗法提供了绝佳机会。我们描述了建立有或没有同源滑膜组织共培养的人骨软骨外植体的方案。此外,还提供了一份详细的方案,用于通过蛋白质免疫印迹和免疫组织化学评估外植组织的蛋白质含量。文中插入了关于所选技术、可能的变体和预期结果的评论。